NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
S Peter Wu
AD Scientific Index 2024
Natural Sciences / Molecular Biology & Genetics
New York University - New York City / United States
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
S Peter Wu's MOST POPULAR ARTICLES
1-)
Treatment with carfilzomib-lenalidomide-dexamethasone with lenalidomide extension in patients with smoldering or newly diagnosed multiple myelomaN Korde, M Roschewski, A Zingone, M Kwok, EE Manasanch, M Bhutani, ...JAMA oncology 1 (6), 746-754, 20153022015
2-)
The IRE1α/XBP1s pathway is essential for the glucose response and protection of β cellsJR Hassler, DL Scheuner, S Wang, J Han, VK Kodali, P Li, J Nguyen, ...PLoS biology 13 (10), e1002277, 20151262015
3-)
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrenceLM Katz, T Hielscher, B Liechty, J Silverman, D Zagzag, R Sen, P Wu, ...Acta neuropathologica 135 (6), 955-963, 2018962018
4-)
Phase II clinical and correlative study of carfilzomib, lenalidomide, and dexamethasone followed by lenalidomide extended dosing (CRD-R) induces high rates of MRD negativity in …N Korde, A Zingone, ML Kwok, EE Manasanch, M Bhutani, N Tageja, ...Blood 122 (21), 538, 2013672013
5-)
Survival of oral tongue squamous cell carcinoma in young adultsJR Oliver, SP Wu, CM Chang, DF Roden, B Wang, KS Hu, D Schreiber, ...Head & neck 41 (9), 2960-2968, 2019502019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept